IP Library › Granted Patent US 12,551,664
Granted Patent B2
US 12,551,664 · App. 19/025,234 · Granted Feb 17, 2026

Introducer sheath systems and methods

Inventors: Kyle P. Taylor (Greenfield, MN); Michael Brenzel (St. Paul, MN); David Matthew Costello (Delano, MN); Robert E. Atkinson (White Bear Lake, MN)
Assignee: Cultiv8 Medical, LLC
A61M25/0662A61M25/0097A61M29/00A61M39/0613A61M2039/062A61M2039/0626A61M2039/0673A61M2205/0216A61M2205/3331A61M2205/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,664
App. No.
19/025,234
Granted
Feb 17, 2026
Kind
B2
Abstract

Introducer sheath systems including a pressure regulator operably coupled to a hemostatic valve, wherein the pressure regulator includes a chamber filled with a gas that is fluidly isolated from the hemostatic valve. The introducer sheath systems may include a tubular sheath, a hub assembly, and a dilator disposed therein connected to a proximal end of the sheath; the hub assembly including a housing and a hemostatic valve disposed therein; a pressure regulator connected to the hub and in fluid communication with the hemostatic valve; and a sealed chamber defined by the pressure regulator, the chamber having an interior, wherein the interior of the chamber is filled with a gas that is fluidly isolated from the hemostatic valve.

Claims (40)

1 . An introducer sheath system, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath;

a dilator extending through the hub assembly and the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

the hemostatic valve comprising a non-collapsible valve body and a collapsible member, wherein the collapsible member closes when a space between the collapsible member and the valve body is pressurized;

a pressure regulator connected to the hub assembly and in fluid communication with the space between the collapsible member and valve body; and

a sealed chamber defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber includes a fixed volume and is fluidly isolated from the space between the collapsible member and the valve body.

2 . The introducer sheath system as in claim 1 , wherein the sealed chamber comprises a closed-cell foam.

3 . The introducer sheath system as in claim 1 , wherein the collapsible member is secured to valve body by an O-ring disposed in a notch of the valve body.

4 . The introducer sheath system as in claim 1 , wherein the sealed chamber comprises a chamber housing.

5 . The introducer sheath system as in claim 1 , wherein the space between the collapsible member and the valve body is filled with a liquid.

6 . The introducer sheath system as in claim 5 , wherein the sealed chamber is filled with a gas.

7 . The introducer sheath system as in claim 6 , wherein the collapsible member comprises a sleeve.

8 . The introducer sheath system as in claim 7 , wherein the collapsible member comprises ePTFE.

9 . The introducer sheath system as in claim 7 , wherein the collapsible member comprises densified ePTFE.

10 . The introducer sheath system as in claim 7 , wherein the collapsible member comprises a laminate of FEP over ePTFE.

11 . The introducer sheath system as in claim 7 , wherein the collapsible member is inverted and wrapped around ends of the valve body.

12 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.70 PSI/F.

13 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.50 PSI/F.

14 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.35 PSI/F.

15 . An introducer sheath system, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath, the hub assembly including a primary port and a secondary port;

a dilator extending through the primary port, the hub assembly and the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

the hemostatic valve comprising a valve body and a collapsible member, wherein the collapsible member closes when a space between the collapsible member and the valve body is pressurized, and wherein the collapsible member is secured to the valve body by an O-ring disposed in a notch of the valve body;

a pressure regulator connected to the hub assembly and in fluid communication with the space between the collapsible member and the valve body; and

a sealed chamber defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber includes a fixed volume and is fluidly isolated from the space between the collapsible member and the valve body.

16 . The introducer sheath system as in claim 15 , wherein the housing of the hub assembly defines a bubble capture chamber with a vertical apex, and wherein a flush line is connected to the bubble capture chamber at the vertical apex to vent air bubbles from the bubble capture chamber.

17 . The introducer sheath system as in claim 16 , wherein the housing defining the bubble capture chamber is transparent to facilitate viewing bubbles in the bubble capture chamber.

18 . The introducer sheath system as in claim 15 , further comprising a brake connected to the housing of the hub assembly, wherein the brake is configured to engage a device inserted into at least one of the primary port and the secondary port.

19 . The introducer sheath system as in claim 15 , wherein the hub assembly includes a connector associated with one of the primary port or secondary port, wherein the connector is configured for connection to ECMO tubing for receiving oxygenated blood flow.

20 . An introducer sheath, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

a brake connected to the housing of the hub assembly, wherein the brake includes a first configuration and a second configuration;

a pressure regulator connected to the hub assembly and in fluid communication with the hemostatic valve, wherein the pressure regulator is positioned coaxially with the hemostatic valve; and

a sealed chamber defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber includes a fixed volume and is filled with a gas that is fluidly isolated from the hemostatic valve.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: CULTIV8 1, LLC
To: CULTIV8 MEDICAL, LLC
Reel/Frame 070263/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: TAYLOR, KYLE P.; BRENZEL, MICHAEL; COSTELLO, DAVID MATTHEW; ATKINSON, ROBERT E.
To: CULTIV8 1, LLC
Reel/Frame 069913/0018 →
Continuity (5)
Continuation 18644816 · Apr 24, 2024
Provisional Application 63591928 · Oct 20, 2023
Provisional Application 63512740 · Jul 10, 2023
Provisional Application 63498637 · Apr 27, 2023
Related Publication 20250170369A1 · May 29, 2025
References Cited (43)
US 4540411A · Bodicky · 1985 [cited by applicant]
US 4580573A · Quinn · 1986 [cited by applicant]
US 5071411A · Hillstead · 1991 [cited by applicant]
US 5161773A · Tower · 1992 [cited by examiner]
US 5360417A · Gravener et al. · 1994 [cited by applicant]
US 5401248A · Bencini · 1995 [cited by applicant]
US 5556387A · Mollenauer et al. · 1996 [cited by applicant]
US 5782817A · Franzel et al. · 1998 [cited by applicant]
US 5871474A · Hermann et al. · 1999 [cited by applicant]
US 5895376A · Schwartz et al. · 1999 [cited by applicant]
US 5989233A · Yoon · 1999 [cited by applicant]
US 6221057B1 · Schwartz et al. · 2001 [cited by applicant]
US 6238373B1 · de la Torre et al. · 2001 [cited by applicant]
US 7673846B2 · Jennings et al. · 2010 [cited by applicant]
US 8002749B2 · Macatangay et al. · 2011 [cited by applicant]
US 8118784B2 · Molgaard-Nielsen · 2012 [cited by applicant]
US 8137321B2 · Argentine · 2012 [cited by applicant]
US 8235943B2 · Breznock et al. · 2012 [cited by applicant]
US 8235946B2 · Molgaard-Nielsen · 2012 [cited by applicant]
US 8858504B2 · Nielsen · 2014 [cited by applicant]
US 9314605B2 · Arcaro et al. · 2016 [cited by applicant]
US 9333332B2 · Eisenkolb et al. · 2016 [cited by applicant]
US 9440059B2 · Moore · 2016 [cited by applicant]
US 9592372B2 · Myers · 2017 [cited by applicant]
US 9884175B2 · Furnish et al. · 2018 [cited by applicant]
US 10155104B2 · Arcaro et al. · 2018 [cited by applicant]
US 10960198B2 · Arcaro et al. · 2021 [cited by applicant]
US 11779742B2 · Chalekian et al. · 2023 [cited by applicant]
US 20030225379A1 · Schaffer et al. · 2003 [cited by applicant]
US 20040172008A1 · Layer · 2004 [cited by applicant]
US 20080142747A1 · Jennings · 2008 [cited by examiner]
US 20110077591A1 · Plicchi · 2011 [cited by examiner]
US 20110270182A1 · Breznock · 2011 [cited by examiner]
US 20150112279A1 · Myers · 2015 [cited by examiner]
US 20210146054A1 · Cully · 2021 [cited by examiner]
US 20210187269A1 · Arcaro et al. · 2021 [cited by applicant]
US 20220339419A1 · Wang · 2022 [cited by examiner]
US 20240207592A1 · Oshimizu · 2024 [cited by applicant]
US 20240245895A1 · Oshimizu · 2024 [cited by applicant]
US 20250032767A1 · Dunlea · 2025 [cited by applicant]
US 20250050071A1 · Geist et al. · 2025 [cited by applicant]
AU 2020279750B2 · 2023 [cited by applicant]
International Search Report and Written Opinion issued for PCT Application No. PCT/US2024/025981, mailed Aug. 16, 2024 (11 pages). [cited by applicant]